𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modulation of hepatitis C virus quasispecies heterogeneity by interferon-α and ribavirin therapy

✍ Scribed by Gonzalez-Peralta, R. P.; Liu, W. Z.; Davis, G. L.; Qian, K. P.; Lau, J. Y. N.


Book ID
121397992
Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
962 KB
Volume
4
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Therapy of hepatitis C: Alpha interferon
✍ O Reichard; R Schvarcz; O Weiland 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

Ribavirin is a nucleoside analogue that has been evaluated as a therapy of chronic hepatitis C alone and in combination with alpha interferon. Ribavirin is well absorbed orally and is typically given in doses of 1,000 to 1,200 mg/d. Three randomized, placebo-controlled studies comprising more than 1